טוען...
CAR T cell therapy for B-cell lymphomas
B-cell non-Hodgkin’s lymphoma (NHLs)is a very heterogonous malignancy with diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL) as the most common subtypes. Standard treatment with anti-CD20 based chemoimmunotherapy is usually very effective for disease control. However a significant p...
שמור ב:
| הוצא לאור ב: | Best Pract Res Clin Haematol |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6716161/ https://ncbi.nlm.nih.gov/pubmed/29909914 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.beha.2018.04.001 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|